NCT00071799 A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care Status COMPLETED Phase PHASE3
NCT00070538 VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT00069992 Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML Status TERMINATED Phase PHASE2
NCT00068523 Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies Status COMPLETED Phase NA
NCT00068276 Cholecalciferol in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00066599 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy Status COMPLETED Phase PHASE2
NCT00066248 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Status COMPLETED Phase PHASE2
NCT00065156 Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality Status COMPLETED Phase PHASE2
NCT00065143 Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00064974 Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes Status COMPLETED Phase PHASE2
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00064311 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT00064090 3-AP and Cytarabine in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00062231 Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer Status TERMINATED Phase NA
NCT00062140 Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00061763 Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias Status COMPLETED Phase PHASE2
NCT00055653 Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders Status COMPLETED Phase PHASE2
NCT00054340 Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT00054327 Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE2